AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Abundant Produce

0.027

0.000

Volume:- -

Turnover:150.33K

Market Cap:2.29M

PE:- -

High:0.027

Open:0.027

Low:0.027

Close:0.027

52wk High:0.027

52wk Low:0.027

Shares:84.85M

Float Shares:39.30M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Abbott Laboratories' End-Markets Remain Healthy Despite Mixed Q1 Performance, RBC Says

MT Newswires Live

GUIDANCE: (ABT) Abbott Laboratories Expects 2026 Adjusted EPS Range $5.38 to $5.58, vs. FactSet Est of $5.16

MT Newswires Live

Sector Update: Health Care Stocks Lower Friday Afternoon

MT Newswires Live

Abbott Laboratories Closes Acquisition of Exact Sciences

MT Newswires Live

Abbott Laboratories' Structural Heart Business Could See Upside From Watchman Trial Results, UBS Says

MT Newswires Live

Is It Time To Revisit Abbott Laboratories (ABT) After Recent Share Price Weakness?

Simply Wall St.

A Look At Abbott Laboratories (ABT) Valuation After Recent Share Price Moves

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ABT.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ABT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ABT.AU\",,,,,undefined,":{"symbol":"ABT.AU","market":"AU","secType":"STK","nameCN":"Abundant Produce","latestPrice":0.027,"timestamp":1787292000000,"preClose":0.027,"halted":3,"volume":0,"delay":0,"changeRate":0,"nameEN":"Abundant Produce","floatShares":39299635,"shares":84848333,"eps":0,"marketStatus":"Halted","change":0,"latestTime":"08-21 16:00:00 AEST","open":0.027,"high":0.027,"low":0.027,"amount":150332.332916766,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.027,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ABT.AU\",,,,,undefined,":{"symbol":"ABT.AU","floatShares":39299635,"roa":"--","roe":"--","lyrEps":0,"shares":84848333,"dividePrice":0,"high":0.027,"amplitude":0,"preClose":0.027,"low":0.027,"week52Low":0.027,"pbRate":"--","week52High":0.027,"institutionHeld":0,"latestPrice":0.027,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.027},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABT.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABT.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2628207285","title":"Abbott Laboratories' End-Markets Remain Healthy Despite Mixed Q1 Performance, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2628207285","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628207285?lang=en_us&edition=fundamental","pubTime":"2026-04-17 22:47","pubTimestamp":1776437225,"startTime":"0","endTime":"0","summary":"Abbott Laboratories'  end-markets remain healthy despite a lower 2026 organic revenue guidance amid fiscal Q1 challenges and mixed performance, RBC Capital Markets said in a Thursday research note.The company faced Q1 headwinds, including a weaker respiratory season, underperformance in the continuous glucose monitoring segment, challenging US structural heart business trends, and roadblocks in the nutrition sector, analysts wrote.The brokerage said it expects 2026 EPS of $5.48 on revenue of $50.54 billion.The company has visibility to accelerate growth in H2, driven by emerging signs of nutrition business recovery, electrophysiology unit growth, improvements in the core lab diagnostics unit, robust performance in established pharmaceuticals, and the integration of Exact Sciences in the cancer diagnostics business, according to the note.The brokerage reiterated its outperform rating on the stock and adjusted its price target to $130 from $135.Price: 96.67, Change: +1.20, Percent Change","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2211815571.USD","LU0882574055.USD","LU2133065610.SGD","SG9999002224.SGD","LU1989763427.SGD","BK4533","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU2089984988.USD","IE0002141913.USD","BK4566","LU1914381329.SGD","LU2237957811.SGD","LU2237957902.USD","LU0289739699.SGD","LU0114720955.EUR","IE00B4R5TH58.HKD","SG9999004303.SGD","SG9999002232.USD","LU1721429402.USD","SGXZ41872573.SGD","IE00BFTCPJ56.SGD","BK4568","LU0266013472.USD","LU2468319806.SGD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4581","LU1057294990.SGD","BK4592","LU0122379950.USD","IE0009355771.USD","LU1691799644.USD","LU0170899867.USD","LU1721429741.USD","SGXZ23171101.USD","BK4585","LU1989763690.USD","BK4588","BK4504","BK4082","ABT","LU2324357040.USD","LU0868494617.USD","LU2112291526.USD","LU0234572021.USD","IE00B2B36J28.USD","ABT.AU","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627973272","title":"GUIDANCE: (ABT) Abbott Laboratories Expects 2026 Adjusted EPS Range $5.38 to $5.58, vs. FactSet Est of $5.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2627973272","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627973272?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:33","pubTimestamp":1776339192,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ABT) Abbott Laboratories Expects 2026 Adjusted EPS Range $5.38 to $5.58, vs. FactSet Est of $5.16","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABT","ABT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626112379","title":"Sector Update: Health Care Stocks Lower Friday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2626112379","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626112379?lang=en_us&edition=fundamental","pubTime":"2026-04-11 01:54","pubTimestamp":1775843654,"startTime":"0","endTime":"0","summary":"Health care stocks declined Friday afternoon, with the NYSE Health Care Index decreasing 0.7% and the State Street Health Care Select Sector SPDR ETF  falling 1.2%.The iShares Biotechnology ETF  dropped 1.8%.In corporate news, Replimune  shares tumbled 19%. The company's biologics license application for vusolimogene oderparepvec to treat unresectable advanced cutaneous melanoma was rejected by the US Food and Drug Administration, the regulator said in a complete response letter.Abbott Laboratories  has been ordered by a jury in Chicago to pay $53 million in compensatory damages to a group of families related to four cases over its infant formula, the Chicago Tribune reported. The families accused the company of allegedly failing to inform them that its infant formula could develop a dangerous intestinal disease in premature infants, the report said. Abbott shares fell 2.9%.Organon  is closing in on a deal to be acquired by Sun Pharmaceutical Industries for $12 billion, The Economic Ti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4533","LU1023059063.AUD","SG9999002232.USD","ABT.AU","LABU","BK4581","IE00BJJMRZ35.SGD","LU1914381329.SGD","LU1989763690.USD","BK4007","BK4559","LU1691799644.USD","BK4585","SGXZ23171101.USD","BK4588","LU2065170008.USD","LU2237957902.USD","IE00BJT1NW94.SGD","LU2237957811.SGD","LU2112291526.USD","LU2065169927.USD","LU0882574055.USD","BK4566","LU0266013472.USD","LU2065171311.SGD","LU0289739699.SGD","LU2324357040.USD","REPL","BK4504","LU2089984988.USD","IE0009355771.USD","LU0058720904.USD","XLV","BK4139","BK4568","LU1721429741.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IBB","OGN","LU1989763427.SGD","LU0122379950.USD","LU1721429402.USD","BK4592","ABT","LU1061106388.HKD","XBI","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621370957","title":"Abbott Laboratories Closes Acquisition of Exact Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2621370957","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621370957?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:25","pubTimestamp":1774272343,"startTime":"0","endTime":"0","summary":"Abbott Laboratories  said Monday it has completed its acquisition of Exact Sciences , making the company its wholly owned subsidiary.Exact Sciences shares ceased trading on Nasdaq following the transaction completion, the company said.Abbott shares were 1.6% higher in Monday premarket trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2089984988.USD","SG9999004303.SGD","LU2468319806.SGD","BK4592","LU1989763690.USD","LU0114720955.EUR","LU1023059063.AUD","LU1914381329.SGD","LU2237957902.USD","SGXZ23171101.USD","SGXZ41872573.SGD","LU1057294990.SGD","LU2211815571.USD","SG9999002224.SGD","LU1989763427.SGD","BK4581","LU2237957811.SGD","LU2112291526.USD","BK4566","EXAS","IE0002141913.USD","IE00B2B36J28.USD","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU0868494617.USD","BK4568","IE00BJJMRZ35.SGD","BK4548","LU0058720904.USD","IE00B4R5TH58.HKD","BK4585","LU2324357040.USD","LU1691799644.USD","BK4504","BK4588","BK4533","LU0882574055.USD","IE0009355771.USD","LU1721429402.USD","ABT","LU2133065610.SGD","LU0289739699.SGD","SG9999002232.USD","LU0170899867.USD","LU0234572021.USD","BK4139","BK4082","IE00BJT1NW94.SGD","LU1861558580.USD","ABT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619086116","title":"Abbott Laboratories' Structural Heart Business Could See Upside From Watchman Trial Results, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2619086116","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619086116?lang=en_us&edition=fundamental","pubTime":"2026-03-13 23:33","pubTimestamp":1773416003,"startTime":"0","endTime":"0","summary":"Abbott Laboratories'  structural heart business could see \"meaningful upside\" from readout of positive results of Boston Scientific's  clinical trial of the Watchman implant at the end of March, UBS said in a note emailed Friday.Positive trial results could spark a broader growth in the structural heart area that could indirectly lift Abbott's MedTech segment through a modest market capture, UBS analysts said. Their scenario analysis suggests that even small market share gains have the potential to raise the MedTech segment's five-year compound annual growth rate to sustainable double-digit growth levels, compared to the consensus of 9.6% over the 2025-2030 period.Although the company's shares have been down 11% year-to-date from 52-week highs partly due to investors' concerns about deceleration in key growth areas within the MedTech segment, the analysts said they believe that the structural heart division remains \"underappreciated.\"UBS reiterated the company's stock rating at buy and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0234572021.USD","BSX.AU","LU1989772923.USD","LU2324357040.USD","BK4588","IE0009355771.USD","LU2491050154.USD","LU0225283273.USD","LU2362541513.USD","LU1721429402.USD","LU1718418525.SGD","BK4581","LU2211815571.USD","IE00BJT1NW94.SGD","BK4504","SG9999002224.SGD","LU0345769128.USD","LU1983299246.USD","LU0823416689.USD","BK4592","LU1914381329.SGD","LU0122379950.USD","LU2133065610.SGD","ABT","LU0882574055.USD","LU0432979614.USD","LU0266013472.USD","LU0058720904.USD","LU1691799644.USD","LU1720051017.SGD","SG9999001176.USD","LU2237957811.SGD","LU0187121727.USD","LU2491049909.HKD","LU1061106388.HKD","LU2357305700.SGD","BSX","ABT.AU","IE00BJJMRZ35.SGD","LU1804176565.USD","LU1989763427.SGD","LU0353189680.USD","LU0048584097.USD","LU2244417387.USD","LU0868494617.USD","IE00BFTCPJ56.SGD","LU1989772840.SGD","BK4585","LU1023059063.AUD","LU0011850046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618939739","title":"Is It Time To Revisit Abbott Laboratories (ABT) After Recent Share Price Weakness?","url":"https://stock-news.laohu8.com/highlight/detail?id=2618939739","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618939739?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:26","pubTimestamp":1773134781,"startTime":"0","endTime":"0","summary":"If you are wondering whether Abbott Laboratories is attractively priced at around US$112.65 today, you are not alone. This article is here to unpack what that price could mean for long term investors.\nThe stock has had mixed returns, with a 1.3% decline over the last 7 days, a 1.6% gain over the last 30 days, and longer term returns of a 9.3% decline year to date, a 16.5% decline over 1 year, 21.7% over 3 years, and 4.5% over 5 years.\nRecent headlines around Abbott have focused on its...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/is-it-time-to-revisit-abbott-laboratories-abt-after-recent-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/is-it-time-to-revisit-abbott-laboratories-abt-after-recent-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4566","LU2468319806.SGD","BK4585","LU1914381329.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","SGXZ41872573.SGD","LU0058720904.USD","LU1061106388.HKD","SG9999002224.SGD","LU0234572021.USD","LU2324357040.USD","LU0170899867.USD","LU2211815571.USD","LU2133065610.SGD","SG9999004303.SGD","BK4592","LU1989763427.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0882574055.USD","LU1989763690.USD","LU2237957811.SGD","SG9999002232.USD","ABT","BK4504","LU0122379950.USD","BK4082","IE0009355771.USD","DCF","LU0266013472.USD","LU2089984988.USD","BK4533","BK4588","SGXZ23171101.USD","LU2237957902.USD","LU0868494617.USD","BK4581","LU0114720955.EUR","LU0289739699.SGD","LU1721429402.USD","LU1057294990.SGD","LU1721429741.USD","ABT.AU","BK4568","IE00BFTCPJ56.SGD","LU1691799644.USD","LU1023059063.AUD","LU2112291526.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613732586","title":"A Look At Abbott Laboratories (ABT) Valuation After Recent Share Price Moves","url":"https://stock-news.laohu8.com/highlight/detail?id=2613732586","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613732586?lang=en_us&edition=fundamental","pubTime":"2026-02-24 03:27","pubTimestamp":1771874843,"startTime":"0","endTime":"0","summary":"Why Abbott Laboratories (ABT) is Back on Investors’ Radar\nAbbott Laboratories (ABT) is drawing fresh attention after recent share price moves, with the stock roughly flat over the past week but showing a gain over the past month and weaker returns over the past year.\nSee our latest analysis for Abbott Laboratories.\nAt a share price of US$112.21, Abbott’s recent 4.46% 1 month share price return contrasts with its weaker year to date share price performance and a 15.27% 1 year total shareholder...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/a-look-at-abbott-laboratories-abt-valuation-after-recent-sha-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/a-look-at-abbott-laboratories-abt-valuation-after-recent-sha-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","LU0114720955.EUR","LU1691799644.USD","LU1989763690.USD","SG9999002224.SGD","SGXZ41872573.SGD","LU0170899867.USD","LU2324357040.USD","BK4568","LU1023059063.AUD","LU1721429741.USD","LU0266013472.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU0234572021.USD","BK4082","LU0882574055.USD","SG9999002232.USD","LU2211815571.USD","LU2237957811.SGD","LU0058720904.USD","LU0289739699.SGD","BK4566","LU0868494617.USD","LU2133065610.SGD","SGXZ23171101.USD","LU1721429402.USD","SG9999004303.SGD","LU0122379950.USD","LU1914381329.SGD","ABT","IE00BFTCPJ56.SGD","BK4504","IE0009355771.USD","IE0002141913.USD","LU2089984988.USD","LU2112291526.USD","ABT.AU","IE00BJJMRZ35.SGD","LU1989763427.SGD","BK4533","IE00B2B36J28.USD","BK4592","IE00BJT1NW94.SGD","BK4581","LU1057294990.SGD","LU1061106388.HKD","LU2237957902.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":27,"code":"91000000","status":"200"}]}}